- Tytuł:
- Efficiency and safety of neoadjuvant PD-1 inhibitor (sintilimab) combined with chemotherapy in potentially resectable stage IIIA/IIIB non-small cell lung cancer: Neo-Pre-IC, a single-arm phase 2 trial
- Autorzy:
- Źródło:
- In eClinicalMedicine February 2024 68
Czasopismo naukowe